{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:42Z","timestamp":1787032902538,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"DOI":"10.7759\/cureus.90161","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T16:02:11Z","timestamp":1755273731000},"source":"Crossref","is-referenced-by-count":1,"title":["Estimating the Burden of Sarcopenia in Adults With Type 2 Diabetes Mellitus: Implications for Metabolic Health"],"prefix":"10.7759","author":[{"given":"Deepika","family":"Paila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghotekar","family":"L.H.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175499","article-title":"Sarcopenia in type 2 diabetes mellitus: study of the modifiable risk factors involved","volume":"12","author":"Sravya SL","year":"2023","unstructured":"Sravya SL, Swain J, Sahoo AK, Mangaraj S, Kanwar J, Jadhao P, Das S. Sarcopenia in type 2 diabetes mellitus: study of the modifiable risk factors involved. J Clin Med. 2023, 12:10.3390\/jcm12175499","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S186600","article-title":"Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship","volume":"12","author":"Mesinovic J","year":"2019","unstructured":"Mesinovic J, Zengin A, De Courten B, Ebeling PR, Scott D. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes. 2019, 12:1057-72. 10.2147\/DMSO.S186600","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S410834","article-title":"Sarcopenia in type 2 diabetes mellitus: study of the modifiable risk factors involved","volume":"16","author":"Chen H","year":"2023","unstructured":"Chen H, Huang X, Dong M, Wen S, Zhou L, Yuan X. Sarcopenia in type 2 diabetes mellitus: study of the modifiable risk factors involved. Diabetes Metab Syndr Obes. 2023, 16:1541-54. 10.2147\/DMSO.S410834","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72414","article-title":"Correlation of anthropometry with plasma atherogenicity indices in subjects with type 2 diabetes mellitus","volume":"16","author":"Sahani JK","year":"2024","unstructured":"Sahani JK, Aggarwal R, Ghotekar LH, Prakash A, Singh K, Gupta P. Correlation of anthropometry with plasma atherogenicity indices in subjects with type 2 diabetes mellitus. Cureus. 2024, 16:e72414. 10.7759\/cureus.72414","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2021.1006","article-title":"Sarcopenic obesity: an emerging public health problem","volume":"13","author":"Ji T","year":"2022","unstructured":"Ji T, Li Y, Ma L. Sarcopenic obesity: an emerging public health problem. Aging Dis. 2022, 13:379-88. 10.14336\/AD.2021.1006","journal-title":"Aging Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-ad08","article-title":"Addendum. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care 2023; 46(suppl. 1):s19-S40","volume":"46","author":"ElSayed NA","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al.. Addendum. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care 2023; 46(suppl. 1):s19-S40. Diabetes Care. 2023, 46:1715. 10.2337\/dc23-ad08","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti KG","year":"2006","unstructured":"Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006, 23:469-80. 10.1111\/j.1464-5491.2006.01858.x","journal-title":"Diabet Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2004.09.012","article-title":"Bioelectrical impedance analysis-part II: utilization in clinical practice","volume":"23","author":"Kyle UG","year":"2004","unstructured":"Kyle UG, Bosaeus I, De Lorenzo AD, et al.. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004, 23:1430-53. 10.1016\/j.clnu.2004.09.012","journal-title":"Clin Nutr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen LK","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P, et al.. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020, 21:300-307.e2. 10.1016\/j.jamda.2019.12.012","journal-title":"J Am Med Dir Assoc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-2310","article-title":"Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS)","volume":"33","author":"Kim TN","year":"2010","unstructured":"Kim TN, Park MS, Yang SJ, et al.. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care. 2010, 33:1497-9. 10.2337\/dc09-2310","journal-title":"Diabetes Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018708","article-title":"A cross-sectional study: associations between sarcopenia and clinical characteristics of patients with type 2 diabetes","volume":"99","author":"Cui M","year":"2020","unstructured":"Cui M, Gang X, Wang G, Xiao X, Li Z, Jiang Z, Wang G. A cross-sectional study: associations between sarcopenia and clinical characteristics of patients with type 2 diabetes. Medicine (Baltimore). 2020, 99:e18708. 10.1097\/MD.0000000000018708","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2537","article-title":"Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study","volume":"30","author":"Park SW","year":"2007","unstructured":"Park SW, Goodpaster BH, Strotmeyer ES, et al.. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007, 30:1507-12. 10.2337\/dc06-2537","journal-title":"Diabetes Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2016.40.2.140","article-title":"Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging","volume":"40","author":"Yoon JW","year":"2016","unstructured":"Yoon JW, Ha YC, Kim KM, et al.. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging. Diabetes Metab J. 2016, 40:140-6. 10.4093\/dmj.2016.40.2.140","journal-title":"Diabetes Metab J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.70255","article-title":"Effects of sulfonylureas and dipeptidyl peptidase 4 inhibitors on percentage body fat change in type 2 diabetes mellitus patients on metformin at 4 and 12 weeks","volume":"16","author":"Goel V","year":"2024","unstructured":"Goel V, Aggarwal R, Prakash A, Ghotekar LH, Bansal P. Effects of sulfonylureas and dipeptidyl peptidase 4 inhibitors on percentage body fat change in type 2 diabetes mellitus patients on metformin at 4 and 12 weeks. Cureus. 2024, 16:e70255. 10.7759\/cureus.70255","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-2202","article-title":"Role of muscle mass and muscle quality in the association between diabetes and gait speed","volume":"35","author":"Volpato S","year":"2012","unstructured":"Volpato S, Bianchi L, Lauretani F, et al.. Role of muscle mass and muscle quality in the association between diabetes and gait speed. Diabetes Care. 2012, 35:1672-9. 10.2337\/dc11-2202","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/nu15194149","article-title":"Sarcopenia as a little-recognized comorbidity of type II diabetes mellitus: a review of the diagnosis and treatment","volume":"15","author":"Salom Vendrell C","year":"2023","unstructured":"Salom Vendrell C, Garc\u00eda Tercero E, Moro Hern\u00e1ndez JB, Cedeno-Veloz BA. Sarcopenia as a little-recognized comorbidity of type II diabetes mellitus: a review of the diagnosis and treatment. Nutrients. 2023, 15:10.3390\/nu15194149","journal-title":"Nutrients"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1263650","article-title":"Pathogenesis and comprehensive treatment strategies of sarcopenia in elderly patients with type 2 diabetes mellitus","volume":"14","author":"Hou Y","year":"2023","unstructured":"Hou Y, Xiang J, Wang B, et al.. Pathogenesis and comprehensive treatment strategies of sarcopenia in elderly patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2023, 14:1263650. 10.3389\/fendo.2023.1263650","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-024-00179-4","article-title":"Unraveling the enigma of sarcopenia and sarcopenic obesity in Indian adults with type 2 diabetes - a comparative cross-sectional study","volume":"10","author":"M Y","year":"2024","unstructured":"M Y, Patel MG, Makwana HH, Kalariya H. Unraveling the enigma of sarcopenia and sarcopenic obesity in Indian adults with type 2 diabetes - a comparative cross-sectional study. Clin Diabetes Endocrinol. 2024, 10:22. 10.1186\/s40842-024-00179-4","journal-title":"Clin Diabetes Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e328312c37d","article-title":"Sarcopenic obesity: definition, cause and consequences","volume":"11","author":"Stenholm S","year":"2008","unstructured":"Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008, 11:693-700. 10.1097\/MCO.0b013e328312c37d","journal-title":"Curr Opin Clin Nutr Metab Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/377549-estimating-the-burden-of-sarcopenia-in-adults-with-type-2-diabetes-mellitus-implications-for-metabolic-health","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T16:02:12Z","timestamp":1755273732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/377549-estimating-the-burden-of-sarcopenia-in-adults-with-type-2-diabetes-mellitus-implications-for-metabolic-health"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.90161","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]}}}